Ursa Major has quietly closed $100 million in new funding, according to documents viewed by TechCrunch and multiple sources.
Every step taken towards simplifying a medication regimen can
Zolpidem For Sale Online Xanax Buy Without Prescription lead to greater clarity and a more fulfilling daily life. When the caregiver’s health declines, it can create a compounding effect on the family dynamic. Healthcare providers are encouraged to have open discussions with their patients about symptoms like numbness,
Alprazolam Usa exploring all avenues for management, including lifestyle changes, dietary modifications, and the use of therapy or medications if warranted. For instance, certain alternative therapies such as acupuncture, physical therapy, and cognitive-behavioral
Purchase Tramadol Without Prescription therapy have gained traction in recent years. Access to appropriate medical care, particularly for those in recovery
Ambien No Rx or dealing with chronic conditions, varies significantly across different demographics and regions. Researchers have found that caffeine may enhance the effectiveness of certain pain
Trusted site to Buy Ambien medications, particularly non-steroidal anti-inflammatory drugs (NSAIDs), by
Order Tramadol Online increasing their absorption and efficacy in the body. Many patients report feeling overwhelmed by their anxiety, which can trigger the fight-or-flight
Real Valium online response
Zopiclone Online even in non-threatening situations. The idea of
Real Valium online food as medicine is gaining traction,
Tramadol Overnight Shipping as evidenced by integrative medicine practices that combine traditional and complementary approaches to care. This is particularly concerning for older adults, who may already be at risk for falls and injuries.
Funders to the Series D include BlackRock and Space Capital. The funding was reportedly closed last October.
The new capital came less than a year after the company closed an $85 million Series C. All told, the company has now raised around $234 million and sought the funding at a $400 million pre-money valuation.
An Ursa Major spokesperson declined to comment “on rumors or speculation.”
Ursa, led by CEO Joe Laurienti, is building a 5,000-pound liquid oxygen and kerosene engine called Hadley and a much larger, 10x more powerful Ripley engine with a 50,000-pound thrust. The company eschews the vertical integration paradigm that has historically dominated the aerospace industry. Instead, it focuses solely on the engine, one of the trickiest parts of a rocket to develop.
“We really like the notion that we are a technology development company, and the companies that are flying rockets today should not be flying the same engine that they architected for their rocket 10 years ago,” Laurienti told TechCrunch in an interview last year. “That’s the paradigm we see in vertical integration.”
Ursa’s public customer pool includes small launch companies Astra, Phantom Space and Stratolaunch. The company has also scored an engine delivery contract with the U.S. Air Force.
Source @TechCrunch
